Clinical Trial Update: Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

View source ↗

Summary

A completed clinical trial evaluating how patient demographics, comorbidities, and concomitant medications influence the severity of fibrosis in non-alcoholic f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Methodist Health System | Conditions: Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis | Status: COMPLETED